drugset / Trial / NCT07300553

Impact Of The Gut Microbiota On Host Cells Energy Metabolism in Health And In Inflammatory Bowel Disease

NCT07300553

Non-randomizedParallel-groupOpen-labelBasic science

Summary

Inflammatory Bowel Disease (IBD) often leads to poor disease control and reduced quality of life. Changes in the gut microbiota may disrupt the energy metabolism of immune cells, contributing to IBD. This study will examine how gut microbiota affects immune cell metabolism in healthy adults and IBD patients. Healthy volunteers will be tested before and after a short antibiotic treatment, while IBD patients will be tested once. Energy metabolism will be measured using SCENITH, a method that analyzes metabolic activity in blood immune cells. Participants will also receive a special form of fiber (13C-labeled inulin) to track how gut bacteria break down and use this nutrient. Blood, urine, and stool samples will be analyzed to follow the metabolic fate of inulin. DNA and RNA from stool will be studied to identify which bacteria metabolize the labeled fiber.

Timeline

Start
2026-01-02
Primary completion
2026-11
Completion
2027-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Amphotericin B Unknown 500 mg Oral
Subject Gentamicine Unknown 80 mg Oral
Subject Vancomycin Other / unclassified 250 mg Oral